Robert DiDomenico
Associate Professor with tenure, College of Pharmacy - Pharmacy Practice
Center Affiliate, Center for Pharmacoepidemiology and Pharmacoeconomic Research (CPR), College of Pharmacy
Assistant Head, Faculty Affairs & Strategic Initiatives, Pharmacy Practice
Contact
Office Phone:
Email:
Related Sites:
About Heading link
Overview:
Dr. DiDomenico, Pharm.D., BCPS-AQ Cardiology, FCCP, HFSA, FACC is an Associate Professor in the Department of Pharmacy Practice, a member of the Center for Pharmacoepidemiology and Pharmacoeconomic Research at the University of Illinois at Chicago (UIC), and Cardiovascular Clinical Pharmacist at the University of Illinois Hospital & Health Sciences System with a practice site in inpatient cardiology. He has also served as Residency Program Director for the UIC PGY2 Cardiology Pharmacy residency, mentoring 10 residents in this program between 2008 – 2020. Dr. DiDomenico received his PharmD (1996) and completed three years of post-doctoral training (Pharmacy Practice Residency, 1997; Cardiovascular Pharmacotherapy Fellowship, 1999) at UIC.
He has authored more than 100 peer-reviewed articles, book chapters, and abstracts on topics related to cardiovascular pharmacotherapy and has gained national recognition as a key opinion leader in the areas of heart failure, anticoagulation, and coronary artery disease. He is also an active member of several organizations including the Board of Pharmacy Specialties (BPS), having served as a member of the inaugural Specialty Council on Cardiology. His organizational engagement has earned him fellowship designation in the American College of Clinical Pharmacy (FCCP), American College of Cardiology (FACC), and the Heart Failure Society of America (FHFSA).
Research Interests:
Dr. DiDomenico joined the tenure track in October, 2017. His research focus is optimizing the use of guideline-directed medical therapies (GDMT) in patients patients with cardiovascular disease, particularly those with heart failure and acute coronary syndrome. He is currently working with a group of investigators across the country investigating optimal parenteral anticoagulation strategies in cardiogenic shock patients treated with the Impella percutaneous left ventricular assist device (pVAD). The Impella pVAD is being used increasingly in patients with cardiogenic shock but there is little guidance for nor consistency in anticoagulation practices during Impella pVAD support. Dr. DiDomenico is also investigating approaches aimed at intensifying GDMT in patients hospitalized for acute heart failure in an effort to improve outcomes, including reducing unplanned rehospitalization. His previous work has demonstrated that many patients with HFrEF whose evidence-based therapies are not at goal doses at the time of hospitalization do not have these therapies intensified prior to discharge, potentially contributing to unplanned readmission.
Dr. DiDomenico is also interested in the scholarship of teaching and learning (SoTL), with interests in item-writing, assessment, and delivery.
Teaching Statement:
Dr. DiDomenico has taught in more than 20 core and elective didactic courses. Additionally, he has precepted more than 130 PharmD students completing introductory and advanced pharmacy practice experiences and more than 160 pharmacy residents (more than 240 learning experiences). He has been awarded Preceptor of the Year by students (2006) and residents (2005, 2008), Teacher of the Year Honorable Mention (2005 by Class of 2007), and nominated for the Golden Apple Award (2008).
He also served as Chair of the Educational Policy Committee from 2008 – 2018 during which time the College of Pharmacy implemented distance-learning technology, expanded to a satellite campus in Rockford, IL, revised and implemented a new curriculum, and was re-accredited.
He has given more than 120 invited talks, many for continuing education credit, at various local, regional, national, and international venues.
Teaching and Supervision Heading link
Block 4: Circulation and Respiration (MDC 604), 3/9/2022 – Present
PDAT 5: Cardiovascular (PHAR 505), 1/10/2022 – 4/29/2022
PDAT 5: Cardiovascular (PHAR 505), 1/10/2022 – 4/29/2022
Spec Project in Pharm Pract (PMPR 390), 1/10/2022 – 4/29/2022
Comparative Effectiveness Research Capstone (PSOP 592), 1/10/2022 – 12/31/2022
Social and Behavioral Pharmacy (PHAR 462), 8/16/2021 – 12/10/2021
College of Pharmacy Colloquium (BPS 425), 8/16/2021 – 12/10/2021
Spec Project in Pharm Pract (PMPR 390), 1/11/2021 – 4/30/2021
PDAT 5: Cardiovascular (PHAR 505), 1/11/2021 – 4/30/2021
Selected Grants
Chicago Metro Vaccine Corps Program, National Center for Advancing Translational Sciences., 6/1/2021 - 5/31/2026, Obligated Amount: $1; No Anticipated Amount Set
Chicagoland COVID Collaborative, National Heart, Lung, and Blood Institute., 6/1/2021 - 5/31/2024, Obligated Amount: $1399943; No Anticipated Amount Set
COVID-19 Vaccination Chicago Rapid Response Team, Chicago Department of Public Health., 2/1/2021 - 8/1/2021, No Obligated Amount Set; No Anticipated Amount Set
PRogram to Educate & VaccinatE uNderserved members of The public (PREVENT), Mobile Care Fdn., 12/16/2020 - 6/15/2022, Obligated Amount: $58337; Anticipated Amount: $58337
CRRT Service Contract, Chicago Department of Public Health., 7/1/2020 - 3/31/2022, Obligated Amount: $1000000; No Anticipated Amount Set
Stratification of Burnout in Health-system Pharmacists: a Focus on the Ambulatory Care, American College of Clinical Pharmacy Ambulatory Care PRN., 2019 - 2019, Obligated Amount: $750; No Anticipated Amount Set
Contemporary Practice Trends to Reversal of Oral Anticoagulants: A US Based National Survey, CSL Behring., 10/1/2018 - 1/31/2023, Obligated Amount: $52600; Anticipated Amount: $52600
PATient Navigator to rEduce Readmissions (PArTNER), Patient-Centered Outcomes Research Institute., 10/2013 - 11/2018, Obligated Amount: $2039.965; No Anticipated Amount Set
PATient Navigator to rEduce Readmissions (PArTNER), Patient-Centered Outcomes Research Institute., 10/2013 - 11/2018, Obligated Amount: $2039.965; No Anticipated Amount Set
Selected Publications
McFarland, MS, Stover, KR, Bhat, S, Coon, S, Cooper, M, DiDomenico, R, Herbert, S, Kessler, S, Lee, M, Maddox, MM, Quidley, AM, Rhoney, D, Wooten, L, Zhou, Y. (2023). Charting a new path forward for pharmacy residency expansion. JACCP Journal of the American College of Clinical Pharmacy. doi:10.1002/jac5.1748.
LaBedz, SL, Prieto-Centurion, V, Mutso, A, Basu, S, Bracken, NE, Calhoun, EA, DiDomenico, RJ, Joo, M, Pickard, AS, Pittendrigh, B, Williams, MV, Illendula, S, Krishnan, JA. (2022). Pragmatic Clinical Trial to Improve Patient Experience Among Adults During Transitions from Hospital to Home: the PArTNER study. Journal of General Internal Medicine, 37, (16), 4103-4111. doi:10.1007/s11606-022-07461-0.
McQuade, BM, Keller, E, Elmes, A, DiDomenico, RJ, Jarrett, JB. (2022). Stratification of burnout in health-system pharmacists during the COVID-19 pandemic: A focus on the ambulatory care pharmacist. JACCP Journal of the American College of Clinical Pharmacy, 5, (9), 942-949. doi:10.1002/jac5.1672.
Beavers, CJ, DiDomenico, RJ, Dunn, SP, Cox, J, To, L, Weeks, P, Trujillo, TC, Jennings, DL. (2021). Optimizing anticoagulation for patients receiving Impella support. Pharmacotherapy, 41, (11), 932-942. doi:10.1002/phar.2629.
Smith, BR, Didomenico, RJ. (2021). Renal Function Assessment and Direct-Acting Oral Anticoagulants Dosing: Are We Entering a New Age?. Circulation: Cardiovascular Quality and Outcomes, 14, (6), E008064. doi:10.1161/CIRCOUTCOMES.121.008064.
Olson, KL, DiDomenico, RJ. (2021). Residency research training: Need to rethink the prescription for success?. JACCP Journal of the American College of Clinical Pharmacy, 4, (6), 664-666. doi:10.1002/jac5.1464.
Baker, WL, Sobieraj, DM, DiDomenico, RJ. (2021). Influence of digoxin on mortality in patients with atrial fibrillation: Overview of systematic reviews. Pharmacotherapy, 41, (4), 394-404. doi:10.1002/phar.2510.
Patel, H, DiDomenico, RJ, Suda, KJ, Schumock, GT, Calip, GS, Lee, TA. (2020). Risk of cardiac events with azithromycin—A prediction model. PLoS ONE, 15, (10 October). doi:10.1371/journal.pone.0240379.
Patel, H, Calip, GS, DiDomenico, RJ, Schumock, GT, Suda, KJ, Lee, TA. (2020). Comparison of Cardiac Events Associated With Azithromycin vs Amoxicillin. JAMA network open, 3, (9), e2016864. doi:10.1001/jamanetworkopen.2020.16864.
Professional Leadership
Task Force on Residency Training, American College of Clinical Pharmacy, 11/1/2021 - Present
Annual Scientific Meeting Moderated Poster Session, Heart Failure Society of America, 9/11/2021 - Present
HFSA Annual Scientific Meeting Programming Committee, Heart Failure Society of America, 9/1/2021 - 9/30/2022
Council on Clinical Cardiology Clincal Pharmacology, 8/16/2021 - Present
Budget & Finance Committee, American College of Clinical Pharmacy, 11/1/2020 - Present
Abstract reviewer, Heart Failure Society of America, 2020 - Present
Research Committee, 1/2020 - Present
Clinical Research Challenge Review Committee, American College of Clinical Pharmacy, 2019 - 2021
Research and Scholarship Committee, 10/2018 - 10/30/2020
Notable Honors
2021, Letter of Commendation, Timothy Killeen
2021, Mentoring Award, American College of Clinical Pharmacy
2017, Fellow, American College of Cardiology (FACC),
2017, Fellow, Heart Failure Society of America (FHFSA),
2013, Fellow, American College of Clinical Pharmacy (FCCP),
2008, Resident Preceptor of the Year, UIC College of Pharmacy
2008, Student Preceptor of the Year Nominee, UIC College of Pharmacy
2008, Golden Apple Award Nominee, UIC College of Pharmacy
2008, Investigator Development Award, American College of Clinical Pharmacy Research Institute
Education
Degrees:
Pre-Pharmacy Studies, University of Illinois at Chicago, United States, 1992
Doctor of Pharmacy (with Honors), University of Illinois at Chicago, United States, 1996
Postgraduate Training:
Cardiovascular Pharmacotherapy Fellowship, University of Illinois at Chicago, United States, 1999
Pharmacy Practice Residency, University of Illinois at Chicago, United States, 1997
Licensures and Certifications
Basic Life Support Provider, American Heart Association, 1996 - Present
Acute Cardiac Life Support Provider, American Heart Association (Chgo), 1996 - Present
Board Certified Pharmacotherapy Specialist, Board of Pharmaceutical Specialties, 2015 - 2022
Added Qualifications in Cardiology, Board of Pharmaceutical Specialties, 2015 - 2022
Pharmacy-Based Immunization Delivery, American Pharmacists Association, 2020 - Present
Selected Presentations
DiDomenico, Robert. (2022 June 13). What about worsening symptoms: role of new drugs.. 18th Annual Meeting of the American Association of Heart Failure Nurses. Orlando, FL.